Responsible oversight of human stem cell research: the California Institute for Regenerative Medicine's medical and ethical standards

Geoffrey P Lomax; Zach W Hall; Bernard Lo

doi:10.1371/journal.pmed.0040114

Responsible oversight of human stem cell research: the California Institute for Regenerative Medicine's medical and ethical standards

PLoS Med. 2007 May;4(5):e114. doi: 10.1371/journal.pmed.0040114.

Authors

Geoffrey P Lomax¹, Zach W Hall, Bernard Lo

Affiliation

¹ California Institute for Regenerative Medicine, San Francisco, California, United States of America. glomax@cirm.ca.gov

Abstract

California voters recently approved $3 billion over 10 years for public funding of stem cell research through the California Institute for Regenerative Medicine (CIRM). Geoffrey Lomax and colleagues discuss the principles that guided the CIRM regulations.

Publication types

Review

MeSH terms

Academies and Institutes / ethics*
Academies and Institutes / legislation & jurisprudence
Academies and Institutes / standards
California
Embryo Research / ethics*
Embryo Research / legislation & jurisprudence
Embryonic Stem Cells*
Ethics Committees, Research / ethics*
Ethics Committees, Research / legislation & jurisprudence
Ethics Committees, Research / standards
Guideline Adherence / standards*
Humans